Skip to main content
. 2012 Apr;50(4):1140–1146. doi: 10.1128/JCM.06852-11

Table 2.

Overview of clinical studies evaluating chromogenic media for detection of ESBL producers and CREa

Chromogenic medium/use Sample(s) (n) Proportion of samples harboring ESBL producers/carbapenem resistant strains in total tested samples (%) Incubation time (h) Comparator(s) Sensitivity (%) Specificity (%) PPV (%) NPV (%) Reference
ESBL GNB detection
    chromID ESBL Fecal (344) 59/528 (11) 24 Brilliance ESBL, MAC + CAZ (30 μg) 94.9 95.5 70.8 98.2 10
Respiratory tract (134)
Wound, urine, vaginal, blood (50)
Fecal (500) 41/500 (8.2) 24 MAC + CAZ (1 μg/ml), 100 94.8 63 100 18
MAC + CTX (1 μg/ml)
Stool (186) 17/256 (6.6) 24 CHROMagar ESBL 88.2 92.9 46.9 99.1 23
Urine (48)
Sputum (12)
Wound (10)
Rectal swab (468) 32/765 (4.2) 24 BLSE 88 94.4 38.7 99.6 22
Urine (255) 48 94 90.5 28.4 99.9
Pulmonary aspiration (42)
Fecal (561) 37/644 (5.7) 18–24 MAC + CAZ (2 μg/ml) 97.7 90.4 ND ND 9
Lower respiratory tract (63)
Wound, ear/nose/throat (20)
    CHROMagar ESBL Stool (186) 17/256 (6.6) 24 chromID ESBL 100 93.3 51.5 100 23
Urine (48)
Sputum (12)
Wound (10)
    Brilliance ESBL Fecal (344) 59/528 (11) 24 chromID ESBL, MAC + CAZ (30 μg) 94.9 95.7 73.7 99.3 10
Respiratory tract (134)
Wound, urine, vaginal, blood (50)
CRE detection
    CHROMagar KPC/Colorex KPC
Rectal swab (139) 33/139 (24) 24 MAC + IPM (1 μg/ml), 84.9 88.7 70 95 1
MAC + IPM, MEM and ERT disks (10 μg)
Rectal swab (126) 46/126 (36.5) 24 and 48 MAC+ IPM (1 μg/ml) 97.8 100 100 98.8 17
Stool (200) 37/200 (18.5) 20 ID Carba 97 96 71.9 25.8 19
Rectal swab (122) 41/122 (33.6) 24 MAC + IPM, MEM and ERT disks (10 μg) 100 98.4 ND ND 24
    ID Carba Stool (200) 37/200 (18.5) 20 Colorex KPC 100 93 78.8 52.9 19
a

CRE, carbapenem-resistant Enterobacteriaceae; PPV, positive predictive value; NPV, negative predictive value; MAC, MacConkey agar; CAZ, ceftazidime; CTX, cefotaxime; IPM, imipenem; MEM, meropenem; ERT, ertapenem; ND, not described.